ReviewNaunyn-Schmiedeberg's archives of pharmacology1994
5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives.
Review in Naunyn-Schmiedeberg's archives of pharmacology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.
- The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis.The journal of headache and pain · 2017Pooled it
- Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.Drug and alcohol dependence · 2012Trial
- Effects of warm needle acupuncture on behavioral pain threshold in a rat model of migraine.Frontiers in neurology · 2025Article
- Provocation of attacks to discover migraine signaling mechanisms and new drug targets: early history and future perspectives - a narrative review.The journal of headache and pain · 2024Review
- Fingerprint-Based Machine Learning Approach to Identify Potent and Selective 5-HTMolecules (Basel, Switzerland) · 2018Article
- Current and prospective pharmacological targets in relation to antimigraine action.Naunyn-Schmiedeberg's archives of pharmacology · 2008Review
- Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence.CNS drugs · 2008Review
- Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.Naunyn-Schmiedeberg's archives of pharmacology · 2007Review
- 5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats.European journal of pharmacology · 2007Article
- Dilatation induced by 5-HT in the middle meningeal artery of the anaesthetised cat.Naunyn-Schmiedeberg's archives of pharmacology · 2004Article
- Functional 5-HT receptors in human occipital artery.Naunyn-Schmiedeberg's archives of pharmacology · 2004Article
- The role of nitric oxide in vascular headache.Pharmacy world & science : PWS · 2003Review
- Sumatriptan elicits both constriction and dilation in human and bovine brain intracortical arterioles.British journal of pharmacology · 2001Article
- Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries.British journal of pharmacology · 1999Article
- Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine.British journal of pharmacology · 1996Article
- Review
- Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs.British journal of pharmacology · 1996Article
- The autonomic nervous system and the regulation of arterial tone in migraine.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 1995Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The hypothesis that 5-hydroxytryptamine (5-HT) acting through 5-HT2C receptors is a key factor in the initiation of migraine has been re-evaluated in the light of recent basic and clinical scientific developments. The key findings are that nitric oxide is an important trigger for migraine, that 5-HT2B/5-HT2C receptors are present on endothelial cells and trigger nitric oxide release when activated and that supersensitivity of the 5-HT2B/5-HT2C receptor is a neurochemical feature predisposing to headache. Taken together the data bring new perspectives to the role of 5-HT acting through 5-HT2C (or closely similar) receptors in the initiation of migraine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.